Seq Ll, Inc. SQL
We take great care to ensure that the data presented and summarized in this overview for SeqLL, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in SQL
Top Purchases
Top Sells
About SQL
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.
Insider Transactions at SQL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 30
2024
|
Daniel Robert Jones Former CEO |
BUY
Open market or private purchase
|
Direct |
1,465
+2.25%
|
$7,325
$5.9 P/Share
|
|
Aug 29
2024
|
Daniel Robert Jones Former CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+1.58%
|
$5,000
$5.49 P/Share
|
|
Aug 15
2024
|
Daniel Robert Jones Former CEO |
BUY
Open market or private purchase
|
Direct |
400
+0.65%
|
$2,400
$6.0 P/Share
|
|
Aug 14
2024
|
Daniel Robert Jones Former CEO |
BUY
Open market or private purchase
|
Direct |
925
+1.5%
|
$4,625
$5.48 P/Share
|
|
Jul 19
2024
|
Prateek Gattani Director |
BUY
Open market or private purchase
|
Direct |
1,300,000
+50.0%
|
-
|
|
Jun 18
2024
|
Robert Barry Machinist Director |
BUY
Open market or private purchase
|
Direct |
728,814
+50.0%
|
$1,457,628
$2.36 P/Share
|
|
Jun 18
2024
|
Christopher Broderick COO & CFO |
BUY
Open market or private purchase
|
Direct |
2,004,237
+50.0%
|
$4,008,474
$2.36 P/Share
|
|
Jun 18
2024
|
Michael Tenore General Counsel & Secretary |
BUY
Open market or private purchase
|
Direct |
1,001,694
+50.0%
|
$2,003,388
$2.36 P/Share
|
|
Jun 18
2024
|
Jeffrey M Jagid Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,735,169
+50.0%
|
$7,470,338
$2.36 P/Share
|
|
Dec 19
2022
|
Douglas Patrick Miscoll Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+1.43%
|
$0
$0.33 P/Share
|
|
Dec 16
2022
|
Douglas Patrick Miscoll Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+1.43%
|
$0
$0.35 P/Share
|
|
Dec 09
2022
|
Daniel Robert Jones Former CEO |
BUY
Open market or private purchase
|
Direct |
5,733
+0.22%
|
$0
$0.39 P/Share
|
|
Sep 27
2022
|
Douglas Patrick Miscoll Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.98%
|
$0
$0.77 P/Share
|
|
Sep 26
2022
|
Douglas Patrick Miscoll Director |
BUY
Open market or private purchase
|
Indirect |
850
+0.84%
|
$0
$0.75 P/Share
|
|
Sep 26
2022
|
Daniel Robert Jones Former CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.1%
|
$0
$0.79 P/Share
|
|
Sep 23
2022
|
Douglas Patrick Miscoll Director |
BUY
Open market or private purchase
|
Indirect |
150
+0.15%
|
$0
$0.76 P/Share
|
|
Sep 22
2022
|
Douglas Patrick Miscoll Director |
BUY
Open market or private purchase
|
Indirect |
2,400
+1.2%
|
$0
$0.79 P/Share
|
|
Sep 02
2022
|
Douglas Patrick Miscoll Director |
BUY
Open market or private purchase
|
Direct |
1,000
+1.03%
|
$0
$0.88 P/Share
|
|
Sep 01
2022
|
Douglas Patrick Miscoll Director |
BUY
Open market or private purchase
|
Direct |
1,100
+1.13%
|
$0
$0.9 P/Share
|
|
Sep 01
2022
|
Douglas Patrick Miscoll Director |
BUY
Open market or private purchase
|
Indirect |
2,687
+2.71%
|
$0
$0.89 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 8.77M shares |
|---|